Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.

scientific article published on 24 November 2011

Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/IJN.S26155
P932PMC publication ID3230568
P698PubMed publication ID22162658

P50authorSalvatore CannistraroQ56419561
Monica BucciantiniQ57313339
Silvia Di AgostinoQ42724855
P2093author name stringTohru Yamada
Anna Rita Bizzarri
Craig W Beattie
Simona Santini
Emilia Coppari
P2860cites workTopors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53Q24299024
ARF-BP1/Mule is a critical mediator of the ARF tumor suppressorQ24306428
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53Q24328775
The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53.Q24536176
Thermodynamic stability of wild-type and mutant p53 core domainQ24648879
p53, the cellular gatekeeper for growth and divisionQ27860990
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationQ28280958
Models for the Specific Adhesion of Cells to CellsQ29616061
p53: puzzle and paradigmQ29618407
Refined procedure of evaluating experimental single-molecule force spectroscopy dataQ31157288
Correction of systematic errors in single-molecule force spectroscopy with polymeric tethers by atomic force microscopy.Q51922818
Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin.Q53814052
Single-Molecule Force Spectroscopy and Imaging of the Vancomycin/d-Ala-d-Ala InteractionQ57990543
Dynamic force spectroscopy on soft molecular systems: improved analysis of unbinding spectra with varying linker complianceQ79193917
Modelling the interaction between the p53 DNA-binding domain and the p28 peptide fragment of AzurinQ82264143
Modeling the interaction between the N-terminal domain of the tumor suppressor p53 and azurinQ83179614
Atomic force spectroscopy in biological complex formation: strategies and perspectivesQ84881047
Interaction of p53 with Mdm2 and azurin as studied by atomic force spectroscopyQ84957244
Dynamic force spectroscopy of parallel individual Mucin1-antibody bondsQ33226563
Detection and localization of single molecular recognition events using atomic force microscopyQ33240545
Affinity-matured recombinant antibody fragments analyzed by single-molecule force spectroscopyQ33293045
Probing the interaction between p53 and the bacterial protein azurin by single molecule force spectroscopyQ33318029
Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.Q33888123
Dynamic strength of molecular adhesion bondsQ33915225
Force spectroscopy of the double-tethered concanavalin-A mannose bondQ34185353
The MDM2-p53 interaction.Q34288001
The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrestQ34336866
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulationQ35089377
Decision making by p53: life, death and cancerQ35116663
Cadherin interaction probed by atomic force microscopyQ35668095
Targeting the p53-MDM2 interaction to treat cancerQ35903526
The complexity of p53 stabilization and activationQ36443523
Restoration of wild-type p53 function in human cancer: relevance for tumor therapy.Q36710840
Detection and localization of individual antibody-antigen recognition events by atomic force microscopyQ36798213
Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurinQ37414986
The application of atomic force spectroscopy to the study of biological complexes undergoing a biorecognition process.Q37683504
A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cellsQ39790640
Noncationic peptides obtained from azurin preferentially enter cancer cellsQ39894720
The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies.Q40024472
Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificityQ40375456
Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer.Q40586177
Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicityQ40678781
Single molecule recognition between cytochrome C 551 and gold-immobilized azurin by force spectroscopy.Q42055933
A 28-Amino-Acid Peptide Fragment of the Cupredoxin Azurin Prevents Carcinogen-Induced Mouse Mammary LesionsQ42907365
A combined atomic force microscopy imaging and docking study to investigate the complex between p53 DNA binding domain and Azurin.Q45916192
Unique complex between bacterial azurin and tumor-suppressor protein p53.Q46507154
Energy landscapes of ligand-receptor couples probed by dynamic force spectroscopyQ47735931
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P304page(s)3011-3019
P577publication date2011-11-24
P1433published inInternational Journal of NanomedicineQ6051502
P1476titleInteraction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy
P478volume6

Reverse relations

cites work (P2860)
Q36746817A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours
Q38747114A nanotechnological, molecular-modeling, and immunological approach to study the interaction of the anti-tumorigenic peptide p28 with the p53 family of proteins
Q90374406Anticancer Actions of Azurin and Its Derived Peptide p28
Q46299094Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.
Q34075830Bacterial proteins and peptides in cancer therapy: today and tomorrow
Q98178391Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines
Q38104247Engineering of bacterial strains and their products for cancer therapy.
Q49189325Imaging and kinetics of the bimolecular complex formed by the tumor suppressor p53 with ubiquitin ligase COP1 as studied by atomic force microscopy and surface plasmon resonance.
Q89879919Investigation of a Direct Interaction between miR4749 and the Tumor Suppressor p53 by Fluorescence, FRET and Molecular Modeling
Q41023571MDM2-MDM4 molecular interaction investigated by atomic force spectroscopy and surface plasmon resonance
Q27001348Single-molecule dynamics and mechanisms of metalloregulators and metallochaperones
Q26774238Spontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatment
Q47109687Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network
Q98771243p28 Bacterial Peptide, as an Anticancer Agent
Q36959166p28, a first in class peptide inhibitor of cop1 binding to p53.

Search more.